IONIS PHARMACEUTICALS INC (IONS)
Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.
Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business